These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 19285259)
1. Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. Borrelli F; Izzo AA Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):33-49. PubMed ID: 19285259 [TBL] [Abstract][Full Text] [Related]
2. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. Ho WS; Barrett DA; Randall MD Br J Pharmacol; 2008 Nov; 155(6):837-46. PubMed ID: 18695637 [TBL] [Abstract][Full Text] [Related]
4. Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells. Matias I; Gonthier MP; Petrosino S; Docimo L; Capasso R; Hoareau L; Monteleone P; Roche R; Izzo AA; Di Marzo V Br J Pharmacol; 2007 Nov; 152(5):676-90. PubMed ID: 17704823 [TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide. Capasso R; Izzo AA J Neuroendocrinol; 2008 May; 20 Suppl 1():39-46. PubMed ID: 18426498 [TBL] [Abstract][Full Text] [Related]
6. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. Hansen HS Exp Neurol; 2010 Jul; 224(1):48-55. PubMed ID: 20353771 [TBL] [Abstract][Full Text] [Related]
7. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent. Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418 [TBL] [Abstract][Full Text] [Related]
8. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα. Karwad MA; Macpherson T; Wang B; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE FASEB J; 2017 Feb; 31(2):469-481. PubMed ID: 27623929 [TBL] [Abstract][Full Text] [Related]
9. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity. Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262 [TBL] [Abstract][Full Text] [Related]
10. [The endocannabinoid system and food intake control]. Rodríguez de Fonseca F Rev Med Univ Navarra; 2004; 48(2):18-23. PubMed ID: 15382609 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry. Lam PM; Marczylo TH; Konje JC Anal Bioanal Chem; 2010 Nov; 398(5):2089-97. PubMed ID: 20835819 [TBL] [Abstract][Full Text] [Related]
13. Cannabinoids and the gut: new developments and emerging concepts. Izzo AA; Sharkey KA Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice. Aviello G; Matias I; Capasso R; Petrosino S; Borrelli F; Orlando P; Romano B; Capasso F; Di Marzo V; Izzo AA J Mol Med (Berl); 2008 Apr; 86(4):413-22. PubMed ID: 18278475 [TBL] [Abstract][Full Text] [Related]
15. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors. Costa B; Comelli F; Bettoni I; Colleoni M; Giagnoni G Pain; 2008 Oct; 139(3):541-550. PubMed ID: 18602217 [TBL] [Abstract][Full Text] [Related]
16. Role of Endocannabinoids in Energy-Balance Regulation in Participants in the Postobese State-a PREVIEW Study. Drummen M; Tischmann L; Gatta-Cherifi B; Cota D; Matias I; Raben A; Adam T; Westerterp-Plantenga M J Clin Endocrinol Metab; 2020 Jul; 105(7):e2511-20. PubMed ID: 32333763 [TBL] [Abstract][Full Text] [Related]
17. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis. Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245 [TBL] [Abstract][Full Text] [Related]
18. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide. Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243 [TBL] [Abstract][Full Text] [Related]
19. Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure. Jumpertz R; Guijarro A; Pratley RE; Piomelli D; Krakoff J J Clin Endocrinol Metab; 2011 Mar; 96(3):787-91. PubMed ID: 21177788 [TBL] [Abstract][Full Text] [Related]
20. FAAH deficiency promotes energy storage and enhances the motivation for food. Touriño C; Oveisi F; Lockney J; Piomelli D; Maldonado R Int J Obes (Lond); 2010 Mar; 34(3):557-68. PubMed ID: 20029375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]